YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Bond markets are throwing out fresh stress signals, with investors racing toward German Bunds and dumping riskier debt across Europe. That kind of flight to safety can punish cyclical stocks and fragile balance sheets, yet it can also shin…
EMD Electronics Part of $200 million multi-year investment strengthening the company's U.S. Electronics footprint, enabling further growth for the industry New 38,000-square-foot Sheboygan Falls, Wisconsin facility expands R&D capabilities…
Company Logo Boost ROI with scalable viral-vector platforms, automated single-use processing, digital quality control, and expanded CDMO capacity through partnerships and acquisitions. Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Cell and Ge…
Company Logo The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digit…
Company Logo Demand for biologics, targeted therapies and personalized medicine is rising, while AI-led protein design and scalable bioprocessing unlock new opportunities. Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Recombinant Proteins Ma…
Company Logo Fetal Bovine Serum Market Gains Momentum as Stem Cell Research, Vaccine Innovation and Advanced Therapies Drive Demand for High-Quality, Ethically Sourced Products Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Bovine Serum…
Company Logo Demand is rising across solar, wearables, sensors and precision medicine, while nanostructuring and safer, durable materials enable smart coatings and light-powered devices. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Photoact…
Company Logo Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magnetic…
Company Logo Boost ROI via automated closed handling, resilient sourcing, tailored portfolios, quality-by-design, validated AI, compliance mapping and lifecycle stewardship. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Grignard Reagents Mar…
Company Logo Oxidative Stress Assay Market Gains Momentum as Chronic Disease Research, Personalized Medicine and Automated High-Throughput Kits Drive Demand Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Oxidative Stress Assay Market Opportun…
Company Logo Cell Culture Media Market Gains Momentum as Serum-Free Formulations, Biologics and Cell Therapies Drive Demand Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Media Market Opportunity, Growth Drivers, Industry Trend A…
Merck KGaA (XTRA:MRK) has received shareholder approval from Bio-Techne investors for its planned acquisition of the US life sciences group. The vote clears a major corporate hurdle in the transaction process, with completion still subject…
MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt…
Company Logo Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharma…
Company Logo Demand is rising with pharmaceutical R&D, stricter drug-testing rules, advanced analytics and environmental monitoring, while trade shifts may reshape sourcing. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Stable Isotope Labele…
Company Logo Site-specific PEGylation is enabling safer, longer-acting biologics, while demand in chronic disease, targeted therapies and biosimilars creates opportunities for services and reagents. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE)…
Company Logo Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "A…
Company Logo Oligonucleotide Synthesis Gains Momentum as Precision Medicine, Gene Editing and Therapeutic Pipelines Drive GMP Capacity Expansion and Partnerships Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Oligonucleotide Synthesis Market…
Company Logo The global single-use bioreactors market is forecast to grow from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, at a 12.0% CAGR. Growth is driven by biologics, biosimilars, vaccine manufacturing, CDMO outsourcing, and…
BOSTON, Sept. 9, 2026 /PRNewswire/ -- PostEra, a biotechnology company specializing in artificial intelligence for small molecule drug discovery and reproductive endocrinology, today announced that EMD Serono, Inc., the Healthcare business…
Company Logo 500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein MarketResearch Use Recombinant Protein Market Dublin…
Company Logo 500-Page Report Ranks Suppliers by Competitive Position Across the Company Evaluation Matrix as Infectious Disease Testing Drives the Largest Application Segment IVD Raw Material MarketIVD Raw Material Market Dublin, Sept. 08,…
Bio-Techne ground sign outside of the office in San Jose, California, USA - June 8, 2023_ By JHVEPhoto Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science reagents, instrum…
Funding brings total capital raised to $62 million as the Company expands pharmaceutical co-development partnerships and accelerates the Hybrid Drug category NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Remepy, the pioneer of Hybrid Drugs, toda…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global gRNA Market size & share revenue was valued at approximately USD 518 Million in 2024…
This article first appeared on GuruFocus. Net Sales: Increased from EUR5,255 million in Q2 2025 to EUR5,434 million in Q2 2026, with organic sales growth of 4.1%. EBITDA pre: Increased from EUR1.46 billion to EUR1.6 billion, with organic g…
Merck KGaA (MKKGY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.57 per share a year ago. These figures are adjusted for non-recurring items. T…
Investing.com-- Merck clocked a stronger second-quarter adjusted profit on Tuesday, aided by strong performances in its life science and electronics divisions, with the company also raising its annual profit outlook. Adjusted earnings befo…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Deep Eutectic Solvents Market size & share revenue was valued at approximately USD 17…
Evinova's full Study Designer with AI suite will be leveraged by Merck KGaA, Darmstadt, Germany to shape future product innovations and accelerate industry-wide transformation BAAR, Switzerland, July 29, 2026--(BUSINESS WIRE)--Evinova, a g…
Merck KGaA (MKKGY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting s…
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Merck KGaA's MilliporeSigma unit has opened a new BioReliance testing facility in Darmstadt, Germany, expanding its biopharm…
MilliporeSigma Announces Opening of BioReliance® Testing Facility in Darmstadt, GermanyThe facility expands access to commercial drug substance and drug product release testing as well as stability testing for biopharmaceutical companies d…
Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 7.2% in the last trading session to close at $10.45. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's…
Company Logo The cell isolation market is projected to grow from USD 4.39 billion in 2026 to USD 7.97 billion by 2031, with a CAGR of 12.7%. Key drivers include the expansion of cell and gene therapy, rising demand for immune cell isolatio…